Literature DB >> 28809135

Detecting signatures of past pathogen selection on human HLA loci: are there needles in the haystack?

Bridget S Penman1, Sunetra Gupta2.   

Abstract

Human leucocyte antigens (HLAs) are responsible for the display of peptide fragments for recognition by T-cell receptors. The gene family encoding them is thus integral to human adaptive immunity, and likely to be under strong pathogen selection. Despite this, it has proved difficult to demonstrate specific examples of pathogen-HLA coevolution. Selection from multiple pathogens simultaneously could explain why the evolutionary signatures of particular pathogens on HLAs have proved elusive. Here, we present an individual-based model of HLA evolution in the presence of two mortality-causing pathogens. We demonstrate that it is likely that individual pathogen species causing high mortality have left recognizable signatures on the HLA genomic region, despite more than one pathogen being present. Such signatures are likely to exist at the whole-population level, and involve haplotypic combinations of HLA genes rather than single loci.

Entities:  

Keywords:  host pathogen coevolution; human evolution; human leucocyte antigen (HLA); pathogen selection

Mesh:

Substances:

Year:  2017        PMID: 28809135     DOI: 10.1017/S0031182017001159

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  3 in total

Review 1.  Host-parasite co-evolution and its genomic signature.

Authors:  Dieter Ebert; Peter D Fields
Journal:  Nat Rev Genet       Date:  2020-08-28       Impact factor: 53.242

Review 2.  Coevolutionary theory of hosts and parasites.

Authors:  Lydia J Buckingham; Ben Ashby
Journal:  J Evol Biol       Date:  2022-01-30       Impact factor: 2.516

3.  Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People.

Authors:  Hamid Reza Ghasemi Basir; Mohammad Mahdi Majzoobi; Samaneh Ebrahimi; Mina Noroozbeygi; Seyed Hamid Hashemi; Fariba Keramat; Mojgan Mamani; Peyman Eini; Saeed Alizadeh; Ghasem Solgi; Da Di
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.